The podcast Epidemic, hosted by Dr. Celine Grounder and Robert Klain, featured episode 21: Are Antibodies the Holy Grail? Guests for this podcast episode are NIBIB's Kaitlyn Sadtler and NIAID's Matthew Memoli, who discuss the SARS-CoV-2 serology study they are conducting at NIH.

Listen and read a transcript.

Dr. Kaitlyn Sadtler of the National Institutes of Health still identifies with her younger self, running through the sprinklers and going to the Frederick County Fair. She earned a bachelor's degree in biological sciences and a Ph.D.and now is an investigator at the NIBIB at the NIH in Bethesda.

For more, visit WJLA-TV.

Researchers at the University of Wisconsin (UW) are adapting a minimally invasive, safer approach to electrically treat pain directly at the source as part of the NIH Helping to End Addiction Long-term (HEAL) Initiative.

To counter drug resistance, scientists must engineer new drugs to kill mutated cancer cells or pathogens. Now, Penn State engineers have developed a new approach for predicting which mutation has expanded the most in a population and should be targeted to design the most effective new drug.

The Tissue Chips in Space initiative is an ambitious collaborative endeavor that brings NIBIB, NCATS, and the ISS U.S. National Laboratory together to rapidly advance tissue chip technology for biomedical research.

The National Institutes of Health on Wednesday announced a new $1.5 billion initiative to rapidly develop coronavirus diagnostics, an effort it says will result in the deployment of “millions of tests per week” by late summer or fall of this year.

Read more at STAT.

The U.S. National Institutes of Health (NIH) today announced a $1.5 billion initiative to speed breakthroughs in diagnostic tests for the virus that causes COVID-19. The program aims to increase the U.S. capacity for SARS-CoV-2 testing up to 100-fold by late summer, in time for the start of the flu season.

Read more at Science.

A competition between researchers is part of a $1.5 billion program that seeks to speed development of accurate, quick and easy-to-use COVID-19 tests, NIH announced Wednesday.

Read HealthDay article at US News & World Report.

NIH has announced a new initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies, a pivotal component needed to return to normal during this unprecedented global pandemic.